1. Home
  2. AORT vs OCS Comparison

AORT vs OCS Comparison

Compare AORT & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$38.57

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$28.68

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AORT
OCS
Founded
1984
2003
Country
United States
Switzerland
Employees
N/A
3
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
AORT
OCS
Price
$38.57
$28.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$49.40
$42.00
AVG Volume (30 Days)
415.0K
189.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
165.62
N/A
EPS
0.21
N/A
Revenue
$298,836,000.00
N/A
Revenue This Year
$14.20
$466.06
Revenue Next Year
$11.20
$479.73
P/E Ratio
$179.90
N/A
Revenue Growth
18.01
N/A
52 Week Low
$22.68
$16.00
52 Week High
$48.25
$30.68

Technical Indicators

Market Signals
Indicator
AORT
OCS
Relative Strength Index (RSI) 58.61 64.37
Support Level $34.15 $19.05
Resistance Level $44.29 $29.19
Average True Range (ATR) 1.37 1.01
MACD 0.39 0.24
Stochastic Oscillator 92.17 82.27

Price Performance

Historical Comparison
AORT
OCS

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: